These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Korantzopoulos P; Galaris D; Papaioannides D; Siogas K Med Sci Monit; 2003 Jun; 9(6):RA120-5. PubMed ID: 12824962 [TBL] [Abstract][Full Text] [Related]
26. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915 [TBL] [Abstract][Full Text] [Related]
27. Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure. Kingery JR; Hamid T; Lewis RK; Ismahil MA; Bansal SS; Rokosh G; Townes TM; Ildstad ST; Jones SP; Prabhu SD Basic Res Cardiol; 2017 Mar; 112(2):19. PubMed ID: 28238121 [TBL] [Abstract][Full Text] [Related]
28. Update on the pharmacological management of congestive heart failure. Thomas B; Vagueiro MC Rev Port Cardiol; 1999 Jun; 18(6):619-25. PubMed ID: 10422459 [TBL] [Abstract][Full Text] [Related]
29. The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets. Banović MD; Ristić AD Curr Pharm Des; 2016; 22(31):4752-4762. PubMed ID: 27306092 [TBL] [Abstract][Full Text] [Related]
30. Cardioprotective effects of baicalein on heart failure via modulation of Ca(2+) handling proteins in vivo and in vitro. Zhao F; Fu L; Yang W; Dong Y; Yang J; Sun S; Hou Y Life Sci; 2016 Jan; 145():213-23. PubMed ID: 26706290 [TBL] [Abstract][Full Text] [Related]
31. Heart Inflammation: Immune Cell Roles and Roads to the Heart. Carrillo-Salinas FJ; Ngwenyama N; Anastasiou M; Kaur K; Alcaide P Am J Pathol; 2019 Aug; 189(8):1482-1494. PubMed ID: 31108102 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress. Ali Sheikh MS; Salma U; Zhang B; Chen J; Zhuang J; Ping Z Oxid Med Cell Longev; 2016; 2016():5893064. PubMed ID: 27379177 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory Biomarkers and Therapeutic Targets in Heart Failure. Papadimitriou L; Kalogeropoulos AP Curr Med Chem; 2015; 22(23):2716-26. PubMed ID: 25876745 [TBL] [Abstract][Full Text] [Related]
35. A Central Role for Monocyte-Platelet Interactions in Heart Failure. Glezeva N; Gilmer JF; Watson CJ; Ledwidge M J Cardiovasc Pharmacol Ther; 2016 May; 21(3):245-61. PubMed ID: 26519384 [TBL] [Abstract][Full Text] [Related]
36. The cellular and physiologic effects of beta blockers in heart failure. Sabbah HN Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699 [TBL] [Abstract][Full Text] [Related]
37. Targeting BNIP3 in inflammation-mediated heart failure: a novel concept in heart failure therapy. Fordjour PA; Wang L; Gao H; Li L; Wang Y; Nyagblordzro M; Agyemang K; Fan G Heart Fail Rev; 2016 Sep; 21(5):489-97. PubMed ID: 27112557 [TBL] [Abstract][Full Text] [Related]
38. Humoral Immunity in Heart Failure. Sarkar A; Rafiq K Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):14-18. PubMed ID: 29773070 [TBL] [Abstract][Full Text] [Related]
39. Regulation of mitochondrial oxidative stress by β-arrestins in cultured human cardiac fibroblasts. Philip JL; Razzaque MA; Han M; Li J; Theccanat T; Xu X; Akhter SA Dis Model Mech; 2015 Dec; 8(12):1579-89. PubMed ID: 26449263 [TBL] [Abstract][Full Text] [Related]
40. Translation of hemodynamic stress to sterile inflammation in the heart. Nakayama H; Otsu K Trends Endocrinol Metab; 2013 Nov; 24(11):546-53. PubMed ID: 23850260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]